Marrone bio announces warrant exchange agreement

Davis, calif., april 30, 2020 (globe newswire) -- marrone bio innovations, inc. (nasdaq: mbii) (the “company” or “marrone bio”) an international leader in sustainable bioprotection and plant health solutions, has signed a warrant exchange agreement with existing institutional investors that immediately reduces the total number of outstanding warrants by approximately 35%, from 52.6 million to 36.5 million.
MBII Ratings Summary
MBII Quant Ranking